Showing results (91-100 of 181) with videos related to

Sort By:
Pageof 19
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 9, 2020
[Effectiveness of L-Carnitine in the Treatment of Fatigue Associated with Chemotherapy in Patients with Gastric Cancer]Hayato Watanabe, Chikara Kunisaki, Yusaku Tanaka, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 28, 2025
Impact of histologically poorly cohesive phenotype as a prognostic factor in patients with pStage II/III gastric cancer undergoing adjuvant chemotherapyChikara Kunisaki, Sho Sato, Kohei Kasahara, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2022
Photoredox-based late-stage functionalization in SAR study for in vivo potent glucosylceramide synthase inhibitorJunsi Wang, Matthew Reynolds, Ignacio Ibáñez, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 8, 2021
Elevated serum tyrosine concentration is associated with a poor prognosis among patients with liver cirrhosisSho Sato, Nozomi Amano, Shunsuke Sato, et al.
Surgical Case Reports|July 1, 2025
Immune Checkpoint Inhibitor-Related Aortitis Treated with Nivolumab for Esophageal Squamous Cell CarcinomaNorihiro Akimoto, Tsutomu Sato, Sho Sato, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 15, 2024
Prognostic factors in patients with pathological T3N0M0 gastric cancer: A multi-institutional, retrospective study (YCOG2202)Hiroki Kondo, Sho Sato, Chikara Kunisaki, et al.
Scientific Reports|May 18, 2018
Locally induced neuronal synchrony precisely propagates to specific cortical areas without rhythm distortionHaruo Toda, Keisuke Kawasaki, Sho Sato, et al.
Surgical Oncology|May 7, 2021
Prognostic impact of dimensional factors in pT1 gastric cancerChikara Kunisaki, Masazumi Takahashi, Sho Sato, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Serum pro-inflammatory cytokine interleukin-6 level is predictive of further decompensation and mortality in liver cirrhosisYuji Ikeda, Hiroki Nago, Masahiro Yamaguchi, et al.
Pageof 19